Cart
sales@molnova.com
(20R)-Ginsenoside Rh1
CAS No. 80952-71-2
(20R)-Ginsenoside Rh1 ( —— )
Catalog No. M19132 CAS No. 80952-71-2
20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 157 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(20R)-Ginsenoside Rh1
-
NoteResearch use only, not for human use.
-
Brief Description20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
-
Description20S, 20R ginsenoside-Rh1 can inhibit the thrombin-induced conversion of fibrinogen to fibrin.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number80952-71-2
-
Formula Weight638.9
-
Molecular FormulaC36H62O9
-
Purity98%
-
Solubility——
-
SMILESO1[C@H]([C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O)O[C@@H]1[C@H]2C([C@H](CC[C@@]2([C@@H]2[C@@](C1)([C@@]1(CC[C@@H]([C@H]1[C@@H](C2)O)[C@@](C)(CCC=C(C)C)O)C)C)C)O)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yu HS,et al. [Chemical constituents from processed rhizomes of Panax notoginseng]. Zhongguo Zhong Yao Za Zhi. 2013 Nov;38(22):3910-7.
molnova catalog
related products
-
Sulfabenzamide
Sulfabenzamide is an antibacterial/antimicrobial.
-
N-Boc-4-pentyne-1-am...
N-Boc-4-pentyne-1-amine is a PROTAC linker, which refers to the alkyl chain composition. N-Boc-4-pentyne-1-amine can be used in the synthesis of the PROTAC MG-277.
-
Terrestrosin D
Terrestrosin D can induce apoptotic cell death and inhibit angiogenesis in xenograft tumor cells, cell cycle arrest and induction of apoptosis in cancer cells and endothelial cells might be plausible mechanisms of actions for the observed antitumor and antiangiogenic activities of terrestrosin D.
